Killian Meara

Patients with diabetes taking a GLP-1 RA of any type had an increased risk of a new GERD diagnosis.

Anti-TNF agents were found to increase the risk of autoimmune disease, especially in psoriasis and lupus.

Vonoprazan appeared to be cost saving below a threshold price of $8.57 per pill.

Post-acute sequelae of SARS-CoV-2 infection (PASC) is a complex condition involving multiple organ systems.

Applications which utilize social media appear to reduce smoking relapse rates.

Device adoption among minority patients with type 1 and type 2 diabetes remains low due to socioeconomic disparities.

The COVID-19 public health emergency is over. What happens now?

A Q&A with Colin Banas, MD, chief medical officer at health care software company DrFirst.

Methamphetamine deaths among American Indian and Native Alaskan men and women significantly increased between 1992 and 2019.

Researchers hope a new study will alleviate patients and clinicians fear of prescribing stimulants for children with ADHD.

Fewer hospitalized patients with COVID-19 pneumonia died when treated with standard care plus either infliximab or abatacept.

The approval of norgestrel (Opill) is expected to help reduce barriers to access by allowing people to obtain the medication without needing to see a health care provider.

Barriers that continue to exist include the challenges of recruiting exceptional pharmacists and the changing landscape of therapies for dermatologic conditions.

The most frequently prescribed weight loss medication was semaglutide (Ozempic), followed by liraglutide (Saxenda), and dulaglutide (Trulicity).

Immune-checkpoint inhibitors were comparably safe and effective in patients with chronic hepatitis B or occult hepatitis B infection.

Electronic inhaler devices record objective inhalation quality data and permit assessment of patient efforts.

The Act4Biosimilars Action Plan aims to highlight key challenges preventing patient access to biosimilars and outline steps to help overcome them.

G2Retro, developed by investigators from Ohio State University, can produce hundreds of new reaction predictions in just a few minutes.

Over 90% of survey respondents said they believed emergency response simulation training should be required annually.

Although excessive use can lead to fatigue, alerts can help proactively identify and prevent drug interactions.

Advisers with the FDA endorse a monoclonal antibody treatment for RSV in children, AstraZeneca and Quell sign a $2 billion agreement, and HSS hopes to strengthen the pediatric workforce.

Nivolumab plus relatlimab showed a clear benefit in progression-free survival, overall survival and objective response rate.

Cytokine signaling pathways in sera from underrepresented minority patients were found to be enriched.

A survey found that only 24.6% of respondents have conducted a skin self-examination in the past 2 months.

A survey shows cancer centers are struggling, Google expands its generative AI into health care, and the WHO announces enhanced collaboration with the Global Fund.

Cue Health gets FDA’s first de novo approval for at-home COVID-19 test, Novavax says its new vaccine will fight new variants and HHS creates new cert standards for peer support workers.

With the rise of prescription digital therapeutics, pharmacists will need to prepare to manage the new paradigms of care.

Merck sues the federal government, the FDA will allow cancer drug imports from China, and a drug from GSK shows promise for endometrial cancer treatment.

Mandy Cohen is set to become the next CDC director, Medicare will cover a new class of Alzheimer’s drugs, and the WHO announces a landmark digital health initiative.

New research suggests that chronotropic incompetence contributes to exercise limitations in Long COVID.